Dana Callow

Managing Partner

30 Rowes Wharf, Suite 400
Boston, Massachusetts 02110

Phone Number: 617-428-5150
E-mail: dana@bmpvc.com

Mr. Callow is the Managing Partner of Boston Millennia Partners. Prior to founding Boston Millennia Partners, Mr. Callow co-founded the predecessor fund of BMP in 1982. Before that, he worked as a Senior Consultant at Braxton Associates, an international strategic planning firm that was formed by professionals from Bain & Co. and Boston Consulting Group. He worked with Fortune 100 companies in strategic planning and implementing merger and acquisition strategies. Prior to working in the management consulting business, Mr. Callow worked in sales and marketing for Tymshare, Inc. (McDonnell-Douglas). He was formerly Lead Director and Chair of the governance committee of PAREXEL International Corporation (Formerly NasdaqGS:PRXL), a $2.5 billion revenue clinical trials management company sold on September 29,2017 for $5 billion. He is a lead investor in, or has served as, a Director of a number of other public and private companies, including ILEX Oncology, Inc. (Nasdaq: ILXO), a cancer pharmaceutical company acquired by Genzyme for $1 billion; MedAptus, Inc., a mobile computing provider of clinical, financial and administrative software solutions to the medical community; and COTA Healthcare, Inc., a precision medicine company that stores, tracks and analyzes longitudinal clinical and billing data of oncology patients with the goal of improving outcomes and reducing costs. Other investment responsibilities included Glycofi Inc., (acquired by Merck, NYSE: MRK); HotJobs, Inc. (acquired by Yahoo, NasdaqGS: YHOO); iVillage, Inc. (acquired by NBC Universal, a subsidiary of General Electric, NYSE: GE); and Tektagen, Inc. (acquired by Charles River Laboratories, NYSE: CRL)

Mr. Callow is a member of the Advisory Board of the Dartmouth/Tuck Center for Private Equity and Entrepreneurship. He is also a member of the Board of Trustees and member and past Chairman of the Investment Committee at Tufts University and on the Board of Overseers at Tufts University Medical School. Mr. Callow is a National Board member for the Leukemia & Lymphoma Society where he chaired its Therapy Acceleration Program committee. Mr. Callow is a graduate of Tufts University and holds an MBA from the Amos Tuck School at Dartmouth.